CalciMedica, Inc. CALC
Set alert
1.40 USD -0.06 -4.11%
At close · Nov 2
1.41 +0.01 +0.74%
After hours · Nov 2, 4:00 PM ET
1.34 Day range 1.75
1.00 52-week range 36.00
- YTD
- -95.75%
- 1 year
- -90.54%
- Open
- 1.74
- Prev close
- 1.46
- Mkt cap
- 9.56M
- Vol
- 164.95K
- Avg vol
- 82.53K
- EPS
- -6.85
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.34
- High
- 1.75
- Forward P/E
- -1.69
- Beta
- 0.00
- Short ratio
- 1.68
- Inst. own
- 43.87%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 12, 2024
- 50-d avg
- 3.46
- 200-d avg
- 4.33
- 1y target
- 17.00
3M chart
Events in this range
- Aug 31, 2026Split: 1 for 5
Signals (10)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 28, 2026 | 5 days ago |
| MACD: Buy Signal | Oct 20, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 12, 2026 | 3 weeks ago |
| RSI: Oversold | Sep 28, 2026 | 1 month ago |
| RSI: Oversold | Sep 24, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 14, 2026 | 1 month ago |
| RSI: Oversold | Aug 31, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 6, 2026 | 2 months ago |
| SMA: Bearish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Aug 3, 2026 | 3 months ago |
Analyst view
Consensus: none
Price target (mean) 17.00 +1114.3% upside
Now 1.40
- Target (low)
- 15.00
- Target (mean)
- 17.00
- Target (high)
- 20.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy1
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 17, 2024 | LUCID CAPITAL MARKETS | Initiated | — | Buy |
| Nov 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 4, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 10, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Jul 9, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 27, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 1, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 16, 2024 | JonesTrading | Initiated | — | Buy |
| Feb 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 29, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Nov 13, 2023 | Oppenheimer | Reiterated | Outperform | Outperform |
| Jul 7, 2023 | EF Hutton | Reiterated | Buy | Buy |
| Jun 20, 2023 | EF Hutton | Initiated | — | Buy |
| May 16, 2023 | Oppenheimer | Reiterated | — | Outperform |
| Mar 24, 2023 | Oppenheimer | Initiated | — | Outperform |